Männedorf, Switzerland, May 21, 2021 -- The Tecan Group (SIX Swiss
Exchange: TECN) today announced that it will present at the UBS Global
Healthcare Virtual Conference next week.
UBS Global Healthcare Virtual Conference
Date: 25 May 2021
Presentation and Fireside Chat: 4:00 pm CET (10:00 am EST) with Dr.
Achim von Leoprechting, CEO, Tecan
Webcast live under the "Investor Relations" tab of Tecan's website
www.tecan.com
A replay of the webcast will be available after the presentation and
will remain available for 30 days.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory
instruments and solutions in biopharmaceuticals, forensics and clinical
diagnostics. The company specializes in the development, production and
distribution of automation solutions for laboratories in the life
sciences sector. Its clients include pharmaceutical and biotechnology
companies, university research departments, forensic and diagnostic
laboratories. As an original equipment manufacturer (OEM), Tecan is also
a leader in developing and manufacturing OEM instruments and components
that are then distributed by partner companies. Founded in Switzerland
in 1980, the company has manufacturing, research and development sites
in both Europe and North America and maintains a sales and service
network in 52 countries. In 2020, Tecan generated sales of CHF 731
million (USD 778 million; EUR 683 million). Registered shares of Tecan
Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Senior Vice President, Corporate Communications & IR
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Attachment
-- Press Release
https://ml-eu.globenewswire.com/Resource/Download/dd450120-ad4d-416c-91af-3f572a0a421b
(END) Dow Jones Newswires
May 21, 2021 09:45 ET (13:45 GMT)